Cempra, Inc. (CEMP)

BestsellerMagazine.com - CATEGORY Headline News: TITLE

Cempra Inc. is a A clinical-stage pharmaceutical company

Last Price $ 3.15

Last Trade

Change $ 0.05

Change Percent 1.61 %

Open $ 3.15

Prev Close $ 3.10

High $ 3.20

low $ 3.05

52 Week High $ 26.95

52 Week Low $ 2.55

Market Cap 165,404,235

PE Ratio 1.09

Volume 570,726

Exchange NGS

CEMP - Market Data & News

CEMP - Stock Valuation Report

> Trade

Cempra Inc. (CEMP) traded on unusually high volume on Sep. 19, as the stock gained 1.61% to close at $3.15. On the day, Cempra Inc. saw 1.31 million shares trade hands on 2,208 trades. Considering that the stock averages only a daily volume of 800,007 shares a day over the last month, this represents a pretty significant bump in volume over the norm.

Generally speaking, when a stock experiences a sudden spike in trading volume, it may be seen as a bullish signal for investors. An increase in volume means more market awareness for the company, potentially setting up a more meaningful move in stock price. The added volume also provides a level of support and stability for price advances.

The stock has traded between $26.95 and $2.55 over the last 52-weeks, its 50-day SMA is now $3.52, and its 200-day SMA $3.98. Cempra Inc. has a P/B ratio of 1.09.

Cempra Inc is a biotechnology company which develops differentiated antibiotics for acute care and community settings. Its goal is to develop treatments for bacterial infectious diseases, mainly respiratory tract infections and staphylococcal infections.

Headquartered in Chapel Hill, NC, Cempra Inc. has 45 employees and is currently under the leadership of CEO David Zaccardelli.

For a complete fundamental analysis analysis of Cempra Inc., check out Equities.com’s Stock Valuation Analysis report for CEMP.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

To get more information on Cempra Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: CEMP’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE : The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

BestsellerMagazine.com, Site News current daily serving News today and the latest news about politics until News lifestyle and sport.

Source : https://www.equities.com/news/cempra-inc-cemp-moves-higher-on-volume-spike-for-september-19

Cempra Inc. (CEMP) Moves Higher on Volume Spike for September 19
Melinta Therapeutics to Participate in Two Upcoming Investor Conferences
CEMPRA (CEMP) Presents At Morgan Stanley 15th Annual Global Healthcare Conference - Slideshow
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cempra, Inc. -- CEMP
Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process Update
Cempra Inc (CEMP.O)
Biotech Movers on Thursday: Cempra Inc (CEMP) And Opexa Therapeutics Inc (OPXA)
CEMPRA, INC. (NASDAQ:CEMP) Files An 8-K Results of Operations and Financial Condition
Cempra Inc's (CEMP) Worst Day Ever Brings Out Option Bears
[LIMITED STOCK!] Related eBay Products